Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 55-61

  Plaxe, Steven C ^a   Saltzstein, Sidney L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER GROWTH; CANCER SCREENING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0032880281     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5524     Document Type: Article

References (36)

1. Surveillance, Epidemiology and End Results (SEER) Program Public Use CD-ROM (1973-1995), National Cancer Institute, DCPC, Surveillance Program, Cancer statistics Branch, released April 1998, based on the August 1997 submission.
2. Dunn J E, Martin P L. Morphogenesis of cervical cancer. Cancer. 20:1967;1899-1906.
3. Barron B A, Richart R M. A statistical model of the natural history of cervical carcinoma based on a prospective study of 557 cases. J Natl Cancer Inst. 41:1968;1343-1353.
4. Fidler H K, Boyes D A, Worth A J. Cervical cancer detection in British Columbia. J Obstet Gynaecol Br Commun. 75:1968;392-404.
5. Barron B A, Richart R M. Statistical model of the natural history of cervical carcinoma. II. Estimates of the transition time from dysplasia to carcinoma-in-situ. J Natl Cancer Inst. 45:1970;1025-1030.
6. Kasgarian M, Dunn J E. The duration of intraepithelial and preclinical squamous cell carcinoma of the uterine cervix. Am J Epidemiol. 92:1970;211-222.
7. Can Med Assoc J. 114:1976;1003-1012.
8. Bryans F E, Boyes D A, Fidler H K. The influence of a cytological screening program upon the incidence of invasive squamous cell carcinoma of the cervix in British Columbia. Am J Obstet Gynecol. 88:1964;898-906.
9. Can Med Assoc J. 114:1976;1013-1026.
10. Hopkins M P, Morley G W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 77:1991;912-917.
11. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol. 85:1995;1017-1021.
12. Hocking G R, Hayman J A, Ostor A G. Adenocarcinoma in situ of the uterine cervix progressing to invasive adenocarcinoma. Aust N Z Obstet Gynaecol. 36:1996;218-220.
13. Poynor E A, Barakat R R, Hoskins W J. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol. 57:1995;158-164.
14. Ostor A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol. 89:1997;88-93.
15. Kaku T, Kamura T, Sakai K. Early adenocarcinoma of the uterine cervix. Gynecol Oncol. 65:1997;281-285.
16. Mulvany N, Ostor A. Microinvasive adenocarcinoma of the cervix: a cytohistopathologic study of 40 cases. Diagn Cytopathol. 16:1997;430-436.
17. Hulka B S. Cancer screening. Cancer. 62:1988;1776-1780.
18. Eifel P J, Morris M, Oswald M J, Wharton J T, Delclos L. Adenocarcinoma of the uterine cervix. Cancer. 65:1990;2507-2514.
19. Im D D, Duska L R, Rosenshein N B. Adequacy of conization margins in adenocarcinoma in situ of the uterine cervix as a predictor of residual disease. Gynecol Oncol. 59:1995;179-182.
20. Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 71:1995;894-897.
21. Steiner N. PDQ Statistics. 1986;B. C. Decker, Toronto. p. 41.
22. Kleinbaum D G, Kupper L L, Muller K E. Applied Regression Analysis and Other Multivariate Methods. 1988;Duxbury Press, North Sciutate. p. 266-268.
23. Schlesselman J J. Case-Control Studies. 1982;Oxford Univ. Press, New York.
24. Howe H L, Lehnherr M, Qualls R Y. Using central cancer-registry data to monitor progress in early detection of breast and cervical cancer (Illinois, United States). Cancer Causes Control. 6:1995;155-163.
25. American Association of Central Cancer Registries. Working Group on Pre-invasive Cervical Neoplasia and Population-Based Cancer Registries Final Subcommittee Report: Rockville, Maryland, April 5-6, 1993, Bethesda, MD, National Cancer Institute, April 1993, pp, 1, - 5.
26. Zheng T, Holford T R, Ma Z, Chen Y. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol. 25:1996;252-258.
27. Tenti P, Romagnoli S, Silini E. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol. 106:1996;52-56.
28. Duggan M A, McGregor S E, Benoit J L. The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol. 26:1995;319-325.
29. Ursin G, Pike M C, Preston-Martin S. Sexual, reproductive and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study. Cancer Causes Control. 7:1996;391-401.
30. Lee K R, Minter L J, Granter S R. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. Am J Clin Pathol. 107:1997;30-35.
31. Zhang W H. Preliminary experience with colposcopic diagnosis of cervical adenocarcinoma. Chung Hua Chung Liu Tsa Chih. 15:1993;218-220.
32. Liao S Y, Brewer C, Zavada J. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasms and cervical carcinomas. Am J Pathol. 145:1994;598-609.
33. Liao S Y, Stanbridge E J. Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 5:1996;549-557.
34. Kudo R, Sasano H, Koizumi M, Orenstein J M, Silverberg S G. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 9:1990;325-336.
35. Rothman K J. Modern Epidemiology. 1986;Little, Brown, Boston. p. 74.
36. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health. 72:1982;1336-1344.